Will Palantir Crash?
AI and data analytics software major Palantir (NASDAQ:PLTR) has been…
Sell
42
TRNS Quote, Financials, Valuation and Earnings
Last price:
$80.20
Seasonality move
:
6.72%
Day range:
$78.89 - $81.04
52-week range:
$67.56 - $147.12
Dividend yield:
0%
P/E ratio:
51.66x
P/S ratio:
2.68x
P/B ratio:
2.62x
Volume:
93.7K
Avg. volume:
141.9K
1-year change:
-33.72%
Market cap:
$750.9M
Revenue:
$278.4M
EPS (TTM):
$1.56
Analysts' Opinion
-
Consensus RatingTranscat has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $97.94, Transcat has an estimated upside of 21.53% from its current price of $80.59.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $85.00 representing 100% downside risk from its current price of $80.59.
Fair Value
-
According to the consensus of 4 analysts, Transcat has 21.53% upside to fair value with a price target of $97.94 per share.
TRNS vs. S&P 500
-
Over the past 5 trading days, Transcat has overperformed the S&P 500 by 4.91% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Transcat does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Transcat has grown year-over-year revenues for 18 quarters straight. In the most recent quarter Transcat reported revenues of $77.1M.
Earnings Growth
-
Transcat earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Transcat reported earnings per share of $0.48.
Enterprise value:
782.1M
EV / Invested capital:
2.45x
Price / LTM sales:
2.68x
EV / EBIT:
40.90x
EV / Revenue:
2.81x
PEG ratio (5yr expected):
1.13x
EV / Free cash flow:
30.33x
Price / Operating cash flow:
28.99x
Enterprise value / EBITDA:
20.75x
Gross Profit (TTM):
$89.5M
Return On Assets:
4.25%
Net Income Margin (TTM):
5.21%
Return On Equity:
5.48%
Return On Invested Capital:
5.15%
Operating Margin:
9%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $230.6M | $259.5M | $278.4M | $70.9M | $77.1M | |
| Gross Profit | $68.4M | $83.8M | $89.5M | $24M | $25.9M | |
| Operating Income | $16.2M | $19.8M | $17.9M | $9.2M | $6.9M | |
| EBITDA | $26.6M | $33.8M | $37.7M | $13.4M | $12.4M | |
| Diluted EPS | $1.40 | $1.62 | $1.56 | $0.80 | $0.48 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $48.9M | $59.7M | $67.6M | $105.2M | $78M | |
| Total Assets | $132.1M | $177.8M | $195.7M | $287.6M | $385.2M | |
| Current Liabilities | $25.1M | $27.7M | $28.3M | $33.5M | $34M | |
| Total Liabilities | $57M | $91.6M | $96.1M | $62.4M | $98.4M | |
| Total Equity | $75.1M | $86.2M | $99.6M | $225.2M | $286.9M | |
| Total Debt | $19.6M | $48.5M | $49.1M | $4.2M | $32.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $17M | $32.6M | $39M | $5.7M | $10.6M | |
| Cash From Investing | -$18.5M | -$41.7M | -$84M | -$19.6M | -$4M | |
| Cash From Financing | $876K | $27.4M | $26.9M | -$1.7M | -$9.4M | |
| Free Cash Flow | $7.5M | $19.3M | $25.8M | $1.5M | $7.9M | |
TRNS
Sector
Market Cap
$750.9M
$611.3M
Price % of 52-Week High
54.78%
77.95%
Dividend Yield
0%
0%
Shareholder Yield
-0.56%
2.29%
1-Year Price Total Return
-33.72%
-0.69%
Beta (5-Year)
0.751
0.775
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$77.81
200-day SMA
Sell
Level
$97.01
Bollinger Bands (100)
Buy
Level
73.27 - 87.73
Chaikin Money Flow
Buy
Level
7.5M
20-day SMA
Sell
Level
$83.99
Relative Strength Index (RSI14)
Sell
Level
48.04
ADX Line
Sell
Level
18.14
Williams %R
Neutral
Level
-67.3295
50-day SMA
Sell
Level
$82.01
MACD (12, 26)
Sell
Level
-1.40
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
8.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.5904)
Buy
CA Score
(Annual)
Level (1.3148)
Buy
Beneish M-Score
(Annual)
Level (-2.6064)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.3776)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.
Stock Forecast FAQ
In the current month, TRNS has received 1 Buy ratings 3 Hold ratings, and 0 Sell ratings. The TRNS average analyst price target in the past 3 months is $97.94.
-
Where Will Transcat Stock Be In 1 Year?
According to analysts, the consensus estimate is that Transcat share price will rise to $97.94 per share over the next 12 months.
-
What Do Analysts Say About Transcat?
Analysts are divided on their view about Transcat share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Transcat is a Sell and believe this share price will drop from its current level to $85.00.
-
What Is Transcat's Price Target?
The price target for Transcat over the next 1-year time period is forecast to be $97.94 according to 4 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is TRNS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Transcat is a Hold. 3 of 4 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TRNS?
You can purchase shares of Transcat via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Transcat shares.
-
What Is The Transcat Share Price Today?
Transcat was last trading at $80.20 per share. This represents the most recent stock quote for Transcat. Yesterday, Transcat closed at $80.59 per share.
-
How To Buy Transcat Stock Online?
In order to purchase Transcat stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Target’s Dividend Worth Buying?
Retail giant Target (NYSE:TGT) has been through an extremely volatile…
Where Will AST SpaceMobile Be In 5 Years?
Ever tried to send a text from the Nevada desert…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
37
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
49
RGC alert for Jun 17
Regencell Bioscience Holdings [RGC] is up 30.47% over the past day.
Buy
75
ARQQ alert for Jun 17
Arqit Quantum [ARQQ] is up 6.36% over the past day.
Buy
59
SYM alert for Jun 17
Symbotic [SYM] is down 3.91% over the past day.
